tiprankstipranks
Pharming Group Nv (PHAR)
NASDAQ:PHAR
US Market
PHAR
Pharming Group
RESEARCH TOOLSreports
Want to see PHAR full AI Analyst Report?

Pharming Group (PHAR) Stock News & Sentiment

225 Followers
Pantginis Reiterates Buy on Pharming as Joenja’s Global Expansion Advances; $37 Price Target Maintained
Premium
Ratings
Pantginis Reiterates Buy on Pharming as Joenja’s Global Expansion Advances; $37 Price Target Maintained
16h ago
PHAR
Pharming Wins EU Green Light for Joenja, First Approved Treatment for APDS
Premium
Company Announcements
Pharming Wins EU Green Light for Joenja, First Approved Treatment for APDS
4d ago
6K
PHAR
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 5/8/2026
Premium
Market News
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 5/8/2026
18d ago
IVA
ATAI
Pharming Posts Mixed Q1 2026 as Joenja® Growth Offsets RUCONEST® Decline and Global Label Expansion Advances
Premium
Company Announcements
Pharming Posts Mixed Q1 2026 as Joenja® Growth Offsets RUCONEST® Decline and Global Label Expansion Advances
20d ago
6K
PHAR
Pharming Group Showcases New Leniolisib Data and Expands Immunology Focus at CIS 2026
Premium
Company Announcements
Pharming Group Showcases New Leniolisib Data and Expands Immunology Focus at CIS 2026
20d ago
6K
PHAR
Pharming Group Sets May 28, 2026 AGM With Key Governance and Capital Measures on Agenda
Premium
Company Announcements
Pharming Group Sets May 28, 2026 AGM With Key Governance and Capital Measures on Agenda
1M ago
6K
PHAR
Pharming Group Files 2025 Annual Report and Form 20-F
Premium
Company Announcements
Pharming Group Files 2025 Annual Report and Form 20-F
2M ago
6K
PHAR
More PHAR News >

PHAR News on the Web

Pantginis Reiterates Buy on Pharming as Joenja’s Global Expansion Advances; $37 Price Target Maintained
TipRanks News
Bullish
Pharming Group Receives EU Approval For Joenja In Rare Immunodeficiency
rttnews
Bullish
Pharming Wins EU Green Light for Joenja, First Approved Treatment for APDS
TipRanks News
Neutral
Pharming’s Joenja granted marketing authorization by European Commission
TipRanks News
Bullish
Pharming Group Sets May 28, 2026 AGM With Key Governance and Capital Measures on Agenda
TipRanks News
Neutral
Pharming initiated with a Buy at Canaccord on growth potential
TipRanks News
Bullish
Pharming initiated with a Buy at Canaccord
TipRanks News
Bullish
Pharming Group Files 2025 Annual Report and Form 20-F
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
PHAR
Sector Average
Media Buzz
This Week3 articles
Weekly Average2.5 articles
News Sentiment
This Week99%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PHAR’s Media Buzz Sentiment?
3 articles about PHAR were published this week. In an average week, 2.5 articles are published.
    What is PHAR’s weekly average amount of articles?
    In an average week, 2.5 articles about PHAR are published.
      What is PHAR’s News Sentiment?
      99% of articles about PHAR were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        IMVTImmunovant
        ROIVRoivant Sciences
        ADOAnteoTech Ltd
        JUNSJupiter Neurosciences, Inc.
        AFPAFT Pharmaceuticals Ltd.
        Showing the stocks with the most bullish news sentiment over the past week